Table of Contents Author Guidelines Submit a Manuscript
Journal of Osteoporosis
Volume 2016, Article ID 5638273, 6 pages
http://dx.doi.org/10.1155/2016/5638273
Research Article

Bone Mineral Density in Postmenopausal Women Heterozygous for the C282Y HFE Mutation

1Westmead Clinical School, Westmead Hospital, Cnr Hawkesbury Road and Darcy Road, Westmead, NSW 2145, Australia
2Department of Endocrinology, Royal North Shore Hospital, St Leonards, NSW 2065, Australia
3Northern Clinical School, University of Sydney, Royal North Shore Hospital, St Leonards, NSW 2065, Australia

Received 21 December 2015; Revised 16 March 2016; Accepted 16 March 2016

Academic Editor: Manuel Diaz Curiel

Copyright © 2016 Jenny E. Gunton et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. F. Delbarre, “Osteoporosis in hemochromatosis,” La Semaine des Hôpitaux de Paris, vol. 36, pp. 3279–3294, 1960. View at Google Scholar
  2. Y. Pawlotsky, Y. Lancien, and G. Roudier, “Bone histomorphometry and osteo-articular manifestations of idiopathic hemochromatosis,” Revue du Rhumatisme et des Maladies Osteo-Articulaires, vol. 46, no. 2, pp. 91–99, 1979. View at Google Scholar · View at Scopus
  3. L. Sinigaglia, S. Fargion, A. L. Fracanzani et al., “Bone and joint involvement in genetic hemochromatosis: role of cirrhosis and iron overload,” Journal of Rheumatology, vol. 24, no. 9, pp. 1809–1813, 1997. View at Google Scholar · View at Scopus
  4. P. Guggenbuhl, Y. Deugnier, J. F. Boisdet et al., “Bone mineral density in men with genetic hemochromatosis and HFE gene mutation,” Osteoporosis International, vol. 16, no. 12, pp. 1809–1814, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. B. B. Yeap, J. Beilin, Z. Shi et al., “The C282Y polymorphism of the hereditary hemochromatosis gene is associated with increased sex hormone-binding globulin and normal testosterone levels in men,” Journal of Endocrinological Investigation, vol. 33, no. 8, pp. 544–548, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. T. Diamond, D. Stiel, M. Lunzer, M. Wilkinson, J. Roche, and S. Posen, “Osteoporosis and skeletal fractures in chronic liver disease,” Gut, vol. 31, no. 1, pp. 82–87, 1990. View at Publisher · View at Google Scholar · View at Scopus
  7. B.-J. Kim, S. H. Ahn, S. J. Bae et al., “Iron overload accelerates bone loss in healthy postmenopausal women and middle-aged men: a 3-year retrospective longitudinal study,” Journal of Bone and Mineral Research, vol. 27, no. 11, pp. 2279–2290, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. S. J. Chon, Y. R. Choi, Y. H. Roh et al., “Association between Levels of serum ferritin and bone mineral density in Korean premenopausal and postmenopausal women: KNHANES 2008-2010,” PLoS ONE, vol. 9, no. 12, Article ID e114972, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. K. S. Lee, J. S. Jang, D. R. Lee et al., “Serum ferritin levels are positively associated with bone mineral density in elderly Korean men: the 2008–2010 Korea National Health and Nutrition Examination Surveys,” Journal of Bone and Mineral Metabolism, vol. 32, no. 6, pp. 683–690, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. M. A. Buyukbese, E. Cetinus, A. Cetinkaya, and S. Aras, “Ferritin levels in postmenopausal women do not seem to play a significant role in osteoporosis,” Southern Medical Journal, vol. 98, no. 8, p. 845, 2005. View at Google Scholar · View at Scopus
  11. L. L. Zhang, X. F. Jiang, H. Z. Ai et al., “Relationship of iron overload to bone mass density and bone tournover in postmenopausal women with fragility fractures of the hip,” Zhonghua Wai Ke Za Zhi, vol. 51, pp. 518–521, 2013. View at Google Scholar
  12. M. F. Basle, Y. Mauras, M. Audran, P. Clochon, A. Rebel, and P. Allain, “Concentration of bone elements in osteoporosis,” Journal of Bone and Mineral Research, vol. 5, no. 1, pp. 41–47, 1990. View at Publisher · View at Google Scholar · View at Scopus
  13. G. Liu, P. Men, G. H. Kenner, and S. C. Miller, “Age-associated iron accumulation in bone: implications for postmenopausal osteoporosis and a new target for prevention and treatment by chelation,” BioMetals, vol. 19, no. 3, pp. 245–251, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. N. Milman, M. Kirchhoff, and T. Jorgensen, “Iron status markers, serum ferritin and hemoglobin in 1359 Danish women in relation to menstruation, hormonal contraception, parity, and postmenopausal hormone treatment,” Annals of Hematology, vol. 65, no. 2, pp. 96–102, 1992. View at Publisher · View at Google Scholar · View at Scopus
  15. E. Rossi, M. K. Bulsara, J. K. Olynyk, D. J. Cullen, L. Summerville, and L. W. Powell, “Effect of hemochromatosis genotype and lifestyle factors on iron and red cell indices in a community population,” Clinical Chemistry, vol. 47, no. 2, pp. 202–208, 2001. View at Google Scholar · View at Scopus
  16. D. L. Van der A, P. H. M. Peeters, D. E. Grobbee, M. Roest, H. A. M. Voorbij, and Y. T. Van Der Schouw, “HFE genotypes and dietary heme iron: no evidence of strong gene—nutrient interaction on serum ferritin concentrations in middle-aged women,” Nutrition, Metabolism and Cardiovascular Diseases, vol. 16, no. 1, pp. 60–68, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. Z. J. Bulaj, L. M. Griffen, L. B. Jorde, C. Q. Edwards, and J. P. Kushner, “Clinical and biochemical abnormalities in people heterozygous for hemochromatosis,” New England Journal of Medicine, vol. 335, no. 24, pp. 1799–1805, 1996. View at Publisher · View at Google Scholar · View at Scopus
  18. H. K. Genant, S. Grampp, C. C. Glüer et al., “Universal standardization for dual X-ray absorptiometry: patient and phantom cross-calibration results,” Journal of Bone and Mineral Research, vol. 9, no. 10, pp. 1503–1514, 1994. View at Google Scholar · View at Scopus
  19. A. C. Looker, L. G. Borrud, J. P. Hughes, B. Fan, J. A. Shepherd, and L. J. Melton III, “Lumbar spine and proximal femur bone mineral density, bone mineral content, and bone area: United States, 2005–2008,” Vital and Health Statistics, no. 251, pp. 1–132, 2012. View at Google Scholar
  20. N. A. Pocock, J. A. Eisman, R. B. Mazess, P. N. Sambrook, M. G. Yeates, and J. Freund, “Bone mineral density in Australia compared to the United States,” Journal of Bone and Mineral Research, vol. 3, no. 6, pp. 601–604, 1988. View at Google Scholar · View at Scopus
  21. L. Valenti, M. Varenna, A. L. Fracanzani, V. Rossi, S. Fargion, and L. Sinigaglia, “Association between iron overload and osteoporosis in patients with hereditary hemochromatosis,” Osteoporosis International, vol. 20, no. 4, pp. 549–555, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. S. G. Zaloumis, K. J. Allen, N. A. Bertalli et al., “Natural history of HFE simple heterozygosity for C282Y and H63D: a prospective 12-year study,” Journal of Gastroenterology and Hepatology, vol. 30, no. 4, pp. 719–725, 2015. View at Publisher · View at Google Scholar · View at Scopus
  23. F. Ahmed, T. Coyne, A. Dobson, and C. McClintock, “Iron status among Australian adults: findings of a population based study in Queensland, Australia,” Asia Pacific Journal of Clinical Nutrition, vol. 17, no. 1, pp. 40–47, 2008. View at Google Scholar · View at Scopus
  24. P. D'Amelio, M. A. Cristofaro, C. Tamone et al., “Role of iron metabolism and oxidative damage in postmenopausal bone loss,” Bone, vol. 43, no. 6, pp. 1010–1015, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. B. Chen, Y.-L. Yan, C. Liu et al., “Therapeutic effect of deferoxamine on iron overload-induced inhibition of osteogenesis in a zebrafish model,” Calcified Tissue International, vol. 94, no. 3, pp. 353–360, 2014. View at Publisher · View at Google Scholar · View at Scopus
  26. P. Guggenbuhl, P. Fergelot, M. Doyard et al., “Bone status in a mouse model of genetic hemochromatosis,” Osteoporosis International, vol. 22, no. 8, pp. 2313–2319, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. L. Lin, E. V. Valore, E. Nemeth, J. B. Goodnough, V. Gabayan, and T. Ganz, “Iron transferrin regulates hepcidin synthesis in primary hepatocyte culture through hemojuvelin and BMP2/4,” Blood, vol. 110, no. 6, pp. 2182–2189, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. J. Truksa, H. Peng, P. Lee, and E. Beutler, “Bone morphogenetic proteins 2, 4, and 9 stimulate murine hepcidin 1 expression independently of Hfe, transferrin receptor 2 (Tfr2), and IL-6,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 27, pp. 10289–10293, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. J. Milet, V. Déhais, C. Bourgain et al., “Common variants in the BMP2, BMP4, and HJV genes of the hepcidin regulation pathway modulate HFE hemochromatosis penetrance,” American Journal of Human Genetics, vol. 81, no. 4, pp. 799–807, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. Q. Yang, J. Jian, S. B. Abramson, and X. Huang, “Inhibitory effects of iron on bone morphogenetic protein 2-induced osteoblastogenesis,” Journal of Bone and Mineral Research, vol. 26, no. 6, pp. 1188–1196, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. E. J. Hibbert, G. R. Fulcher, L. Coyle, F. Gates, P. Clifton-Bligh, and D. Stiel, “Case report: effect of venesection on bone mineral density in an eugonadal woman with haemochromatosis,” Journal of Gastroenterology and Hepatology, vol. 14, no. 2, pp. 176–178, 1999. View at Publisher · View at Google Scholar · View at Scopus